Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismEGFR T790M inhibitors [+1] |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ Not yet recruitingNot ApplicableIIT Effect of remifentanil combined with remimazolam on hypotension after induction of anesthesia in elderly patients: a randomized single-blind controlled trial
A Study on the Efficacy and Cost-Effectiveness of Venetoclax in Managing Leukocytosis During Induction Therapy for Acute Promyelocytic Leukemia
/ Not yet recruitingPhase 1IIT A randomized, single-blind, placebo-controlled, phase I clinical study of the safety and efficacy of nebulized extracellular vesicles of human umbilical mesenchymal stem cells in the treatment of pulmonary fibrosis
100 Clinical Results associated with Linyi People’s Hospital
0 Patents (Medical) associated with Linyi People’s Hospital
100 Deals associated with Linyi People’s Hospital
100 Translational Medicine associated with Linyi People’s Hospital